RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:99027

Adult-onset autosomal dominant leukodystrophy

low confidenceDisorder

Also known as: ADLD · Adult-onset autosomal dominant demyelinating leukodystrophy

Publications

3,945

Trials

0

Interventional, condition-specific

Researchers

842

Distinct authors in sample

Gene link

LMNB1

Strong

Readiness

5/6

Stages with a signal

Clinical definition (Orphanet)

A rare, slowly neurological disorder involving central nervous system demyelination, leading to autonomic dysfunction, and mild cognitive impairment.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (3)

adult-onset autosomal dominant demyelinating leukodystrophy · adult-onset autosomal dominant leukodystrophy · leukodystrophy, adult-onset, autosomal dominant

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

5/6 stages with a signal

No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.

  1. Gene identifiedPresent

    Strong — LMNB1

  2. LiteraturePresent

    3,945 matched papers (3,006 in last 10 years) Source

  3. Phenotype characterisedPresent

    83 HPO annotations (e.g. Leukodystrophy; Constipation; Spasticity) Source

  4. Animal modelPresent

    3 genotype models (Mus musculus) Source

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialPartial

    None under the specific name; 31 for broader category leukodystrophy

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (LMNB1).

GenCC classification: Strong.

Phenotypes (Monarch / HPO)

83

Associated phenotypes · MONDO:0008215

  • Leukodystrophy
  • Constipation
  • Spasticity
  • Ataxia
  • Decreased sweating due to autonomic dysfunction

Showing 5 of 83 — open Monarch for the full list.

Animal models (Monarch / Alliance)

3

Model associations linked to this Mondo ID

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

3,945

3,945 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

3,945 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

3,006 in the last 10 years · low confidence

Phrase hits: 145 · MeSH hits: 1

Open Europe PMC search

Who's working on it?

842

Distinct author names in 146 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Cortelli P9 papers · 2021

    Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto delle Scienze Neurologiche di Bologna, Clinica Neurologica, Ospedale Bellaria, Bologna, Italy; and Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

    Papers in Europe PMC
  2. 02
    Capellari S7 papers · 2018

    Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto delle Scienze Neurologiche di Bologna, Clinica Neurologica, Ospedale Bellaria, Bologna, Italy; and Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

    Papers in Europe PMC
  3. 03
    Fu YH7 papers · 2014

    Department of Neurology, University of California, 1550 Fourth street, UCSF-Mission Bay, Rock Hall 548, San Francisco, CA 94158, USA. ying-hui.fu@ucsf.edu.

    Papers in Europe PMC
  4. 04
    Melberg A7 papers · 2015

    Department of Neuroscience and Neurology, Uppsala University, Uppsala, Sweden.

    Papers in Europe PMC
  5. 05
    Gasparini L6 papers · 2018

    Dept. of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy. laura.gasparini@abbvie.com.

    Papers in Europe PMC
  6. 06
    Raininko R6 papers · 2015

    Department of Radiology, Uppsala University, Uppsala, Sweden.

    Papers in Europe PMC
  7. 07
    Lin ST5 papers · 2014

    Department of Neurology and Howard Hughes Medical Institute, University of California, San Francisco, CA 94158.

    Papers in Europe PMC
  8. 08
    Worman HJ5 papers · 2014

    Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA. hjw14@columbia.edu

    Papers in Europe PMC
  9. 09
    Adam SA4 papers · 2015

    Department of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

    Papers in Europe PMC
  10. 10
    Brusco A4 papers · 2015

    Department of Medical Sciences, University of Torino, Torino 10126, Italy, Città della Salute e della Scienza, University Hospital, Medical Genetics Unit, Torino 10126, Italy.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 31 trials are registered for leukodystrophy, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

low confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

31 interventional trials matched leukodystrophy, the broader category — listed below. Those studies are not counted in the condition-specific total.

Broader category: leukodystrophy

31

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 32 · after dedupe 32 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 32 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Uncertain / not reviewed (32)

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Adult-onset autosomal dominant leukodystrophy — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Adult-onset autosomal dominant leukodystrophy" OR "Adult-onset autosomal dominant demyelinating leukodystrophy" OR "leukodystrophy, adult-onset, autosomal dominant") OR (MESH:"Leukodystrophy, Demyelinating, Adult-Onset, Autosomal Dominant") OR ("LMNB1" OR "LMNB1 syndrome" OR "LMNB1-related")

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Leukodystrophy, Demyelinating, Adult-Onset, Autosomal Dominant

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Adult-onset autosomal dominant leukodystrophy" OR "Adult-onset autosomal dominant demyelinating leukodystrophy" OR "leukodystrophy, adult-onset, autosomal dominant" OR "Leukodystrophy, Demyelinating, Adult-Onset, Autosomal Dominant"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"leukodystrophy"

Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: ADLD

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (3945) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-27T05:54:14.369Z